Why Biology Is Not Destiny
By M.W. Feldman and Jessica Riskin,
The New York Review
| 04. 21. 2022
You must know the parable about the frog that sits in a pot of water being gradually heated, allowing itself to be boiled alive: because the change happens gradually, it never realizes it should leap out. Reading Kathryn Paige Harden’s book The Genetic Lottery: Why DNA Matters for Social Equality is a similar experience, as the author ingenuously points out. “Like a frog being slowly boiled alive,” she observes, readers follow her argument “from an uncontroversial premise to a highly controversial one.” Harden’s “uncontroversial premise” in this case is that siblings raised in the same family share a childhood environment and 50 percent of their DNA randomly assigned at conception, and are therefore like subjects in a controlled study of genetic differences. Ask anyone with a sibling whether their own childhood environment was the same as their sibling’s and you’ll quickly disprove Harden’s claim that her premise is uncontroversial. But putting that objection aside and sitting patiently as Harden increases the heat, we’ll arrive at her “highly controversial” assertion that “if siblings who differ genetically also have corresponding differences in...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...